Also, in rat xenografts derived from CD9-silenced NCH644 and NCH421k cells, there was significantly decreased expression of SOX2, but not of nestin, which suggests the involvement of CD9 in the maintenance of cell stemness during de-differentiation to a malignant GBM. This evidence concerns the gene SOX2 and glioblastoma.